Details
Banafsheh Fathieh is a founding partner at Faction VC and an advisor at Lightspeed Venture Partners, having previously worked at Merrill Lynch, CIM Group, OTOY, OCV, Prosus Ventures. She holds a Bachelor of Science degree from Georgetown University, USA.
Education Experience
Related Figures
Amy Wu
Amy Wu is currently the Partner at Menlo Ventures.Previously he worked at Lightspeed Venture and FTX Ventures. He graduated from Harvard University.
Rashid Ajami
Rashid Ajami is the co-founder of Metropolis and previously the founder of B2B2C White Label and community platform Connectt. He graduated from Georgetown University.
Clara Boh
Clara Boh is a partner at Faction VC. She is a graduate of the National University of Singapore and the Copenhagen Business School in Denmark.
Charles Moran
Charles Moran is the COO of North Island Ventures. He is a graduate of Georgetown University and UCLA Anderson School of Management.
Jude Ogene
Jude Ogene is currently the General Counsel & Chief Compliance Officer at OpenNode.Previously he worked at Paxful. He graduated from Georgetown University.
Jeffrey Yang
Jeffrey Yang is the founder and CEO of R2. Previously, he was co-founder, CMO and Head of Business Development at Lumoz and ZKFair. Earlier, he worked at ZKSwap and 6Block, the Qtum Foundation.
Charles Naut
Charles Naut is co-founder and CTO of Rain and previously worked at Lightspeed Venture. He graduated from Stanford University in the United States.
Warren Wynn
Warren Wynn is the head of trading operations at Flowdesk and previously worked at Genesis. He graduated from Georgetown University.
John Delaney
John Delaney is the co-founder and CEO of Crown, with over 10 years of experience in the cryptocurrency and financial markets sectors. He holds a Juris Doctor degree from Georgetown University and a Bachelor of Arts in International Relations from the University of Washington.
Patrick Joyce
Patrick Joyce is the co-founder and COO of ResearchHub and the founder of Knowledgr, a medical student dedicated to breaking down barriers to participation in the scientific community. In particular, he hopes to revolutionize the understanding of human biology and lead to incredible clinical applications.
